Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose

The impact of donor lymphocyte infusion (DLI) initial cell dose on its outcome is known in patient with chronic myeloid leukemia, but limited in patients with other hematological malignancies. In this retrospective study, we evaluated the effect of initial DLI CD3+ cell dose on graft-versus-host dis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bar, Merav, Sandmaier, Brenda M., Inamoto, Yoshihiro, Bruno, Benedetto, Hari, Parameswaran, Chauncey, Thomas, Martin, Paul, Storb, Rainer, Maloney, David G., Storer, Barry, Flowers, Mary E.D.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3846289/
https://ncbi.nlm.nih.gov/pubmed/23523892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2013.03.001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars